SIM
IART icon

Strategic Investment Management’s Integra LifeSciences IART Stock Holding History

Strategic Investment Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9,066
Closed -$307K – 126
2015
Q4 		$307K Sell
9,066
-690
-7% -$21.6K 0.17% 37
2015
Q3 		$290K Sell
9,756
-906
-8% -$28.3K 0.11% 43
2015
Q2 		$293K Buy
+10,662
New +$284K 0.19% 52

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Strategic Investment Management's IART Position: Q1 2016 in Review

Strategic Investment Management sold out of Integra LifeSciences (IART) in Q1 2016, closing a stake of 9,066 shares — an estimated $307K sold.

Strategic Investment Management first reported a position in IART in Q2 2015 and held it in 3 quarters. The position peaked at $307K in Q4 2015. 194 funds tracked by Wall St. Rank hold IART as of Q1 2016.

  • Strategic Investment Management reported no remaining Integra LifeSciences position as of Q1 2016 after selling out during the quarter.
  • Strategic Investment Management sold 9,066 Integra LifeSciences shares in Q1 2016, an estimated $307K.
  • Strategic Investment Management first reported a position in Integra LifeSciences in Q2 2015 and held it in 3 quarters.
  • Strategic Investment Management's Integra LifeSciences position peaked at $307K in Q4 2015.
  • 194 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2016.

Based on Strategic Investment Management's 13F filing for Q1 2016, filed 16 May 2016.